Home › NDC Lookup › RxCUI directory › RxCUI 1012904

Carbinoxamine maleate 4 MG Oral Tablet — RxCUI 1012904

RxNorm drug concept · Semantic clinical drug
RxCUI 1012904 Semantic clinical drug · SCD ● Current RxNorm concept 3 FDA products 4 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1012904
Official nameCarbinoxamine maleate 4 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped3
Package NDCs mapped4
Reported Medicaid activity (SDUD)10,493 prescriptions · 17 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Carbinoxamine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It relieves symptoms of allergies, such as allergic rhinitis, allergic eye irritation, hives, and dermatographism. It can also be added after a severe allergic reaction is controll...
  • Yes, drowsiness is one of its most common effects, along with dizziness. Don't drive or operate machinery until you know how it affects you. Avoid alcohol and other sedating medici...
  • Tablets and oral solution such as Carbzah and RyVent are taken on an empty stomach with water. Karbinal and the generic extended-release suspension are taken every 12 hours, and yo...
  • Never to a child under 2, because deaths have been reported. For children 2 and older, your prescriber sets the dose carefully. Younger children may become excited rather than slee...
📖 Read our full Carbinoxamine guide →

🕸️ Concept Web — How Carbinoxamine maleate 4 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Carbinoxamine maleate 4 MG Oral Tablet RxCUI 1012904

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Carbinoxamine 20220
    • Carbinoxamine maleate 91066
  2. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Carbinoxamine Oral Tablet 371277
    • Carbinoxamine maleate Oral Tablet 2649534
    • Carbinoxamine Oral Product 1160575
    • Carbinoxamine Pill 1160576
    • Carbinoxamine maleate Oral Product 2659504
    • Carbinoxamine maleate Pill 2662970
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Carbinoxamine maleate 4 MG 1012680

Showing up to 8 concepts per family — 11 of 12 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Carbinoxamine maleate 4 MG SCDC · 1012680
  • Carbinoxamine Oral Tablet SCDF · 371277
  • Carbinoxamine maleate Oral Tablet SCDFP · 2649534
  • Carbinoxamine Oral Product SCDG · 1160575
  • Carbinoxamine Pill SCDG · 1160576
  • Carbinoxamine maleate Oral Product SCDGP · 2659504
  • Carbinoxamine maleate Pill SCDGP · 2662970

📦 FDA Products & Package NDCs

3 products · 4 package NDCs
4 package NDCs map to RxCUI 1012904 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
44523-0825-01 1 BOTTLE in 1 CARTON (44523-825-01) / 100 TABLET in 1 BOTTL... Carbinoxamine Maleate Biocomp Pharma, Inc. 2021-06-28
64950-0211-01 100 TABLET in 1 BOTTLE, PLASTIC (64950-211-01) Carbinoxamine Maleate Genus Lifesciences Inc. 2023-08-02
64950-0243-04 118 mL in 1 BOTTLE, PLASTIC (64950-243-04) Carbinoxamine Maleate Genus Lifesciences Inc. 2023-06-09
64950-0243-16 473 mL in 1 BOTTLE, PLASTIC (64950-243-16) Carbinoxamine Maleate Genus Lifesciences Inc. 2023-06-09
Observed labelers: Genus Lifesciences Inc. (3) · Biocomp Pharma, Inc. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.